Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.

Autor: Elsherif L; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Tang Y; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA., Patillo KL; Office of Clinical Trials, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Wichlan D; Division of Hematology, University of North Carolina, Chapel Hill, North Carolina, USA., Ogu UO; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Landes K; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., McCune P; Office of Clinical Trials, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Scott LC; College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Gulledge W; College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Woodland WH; College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Nelson M; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Loehr LR; Division of General Medicine and Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA., Cronin RM; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Desai PC; Levine Cancer Institute - Atrium Health, Wake Forest School of Medicine, Charlotte, North Carolina, USA., Zhou LY; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA., Pollock DM; Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Zou F; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA., Cai J; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA., Derebail VK; Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ataga KI; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1963-1973. Date of Electronic Publication: 2024 Sep 03.

Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.

Autor: Ogu UO; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Mukhopadhyay A; Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA., Patel K; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Nelson MN; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Strahan KS; Northwest Campus Library, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Wu L; Research and Learning Services, Health Science Library, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Smeltzer MP; Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA., Ataga KI; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 466-474. Date of Electronic Publication: 2023 Nov 29.

Sickle cell disease in the new era: advances in drug treatment.

Autor: Lee MT; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, Children's Hospital North 10th Floor, Room 10-09 A3959 Broadway, New York, NY 10032, USA. Electronic address: ml653@cumc.columbia.edu., Ogu UO; Center for Sickle Cell Disease, The University of Tennessee Health Science Center, Department of Medicine-Hematology, 880 Madison Avenue, Memphis, TN 38103, USA. Electronic address: uogu@uthsc.edu.

Publikováno v: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2022 Oct; Vol. 61 (5), pp. 103555. Date of Electronic Publication: 2022 Aug 29.

Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.

Autor: Tolu SS; Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, 111 East 210th street, Bronx, NY, 10467, USA. st3406@cumc.columbia.edu., Crouch A; Department of Medicine, Division of Hematology, Albert Einstein College of Medicine, Bronx, NY, USA., Choi J; Department of Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, NY, USA., Gao Q; Department of Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, NY, USA., Reyes-Gil M; Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA., Ogu UO; Department of Medicine, Division of Hematology/Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, TN, USA., Vinces G; Department of Family and Social Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA., Minniti CP; Department of Medicine, Division of Hematology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.

Publikováno v: Annals of hematology [Ann Hematol] 2022 Mar; Vol. 101 (3), pp. 541-548. Date of Electronic Publication: 2022 Jan 18.

L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality.

Autor: Ogu UO; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.; Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee., Thomas M; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., Chan F; LeMed Specialty Pharmacy, Bronx, New York.; Vivo Health Specialty Pharmacy, New Hyde Park, New York., Vattappally L; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., Sebastian G; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., Crouch A; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., You S; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York., Minniti CP; Department of Medicine, Division of Hematology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.

Publikováno v: American journal of hematology [Am J Hematol] 2021 Jan; Vol. 96 (1), pp. E38-E40. Date of Electronic Publication: 2020 Oct 29.